Lipocine Stock Performance
| LPCN Stock | USD 5.44 0.12 2.26% |
On a scale of 0 to 100, Lipocine holds a performance score of 9. The company secures a Beta (Market Risk) of 1.43, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lipocine will likely underperform. Please check Lipocine's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Lipocine's current price movements will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.26 | Five Day Return (10.97) | Year To Date Return 90.21 | Ten Year Return (95.94) | All Time Return (96.80) |
Last Split Factor 1:17 | Last Split Date 2023-05-12 |
1 | Lipocine transitions TLANDO commercialization to Verity Pharma | 02/02/2024 |
2 | Exercise or conversion by Mahesh Patel of 145000 shares of Lipocine subject to Rule 16b-3 | 02/09/2024 |
3 | Lipocine Now Covered by StockNews.com - AmericanBankingNEWS | 02/15/2024 |
4 | Lipocine Research Coverage Started at StockNews.com | 03/05/2024 |
5 | Lipocine to Release Quarterly Earnings on Friday | 03/07/2024 |
6 | Acquisition by Krista Fogarty of 991 shares of Lipocine subject to Rule 16b-3 | 03/08/2024 |
7 | Is Lipocine Inc a Stock to Watch After Gaining 12.91 percent This Week - InvestorsObserver | 03/26/2024 |
8 | StockNews.com Begins Coverage on Lipocine - Defense World | 04/02/2024 |
9 | Lipocine reports positive results from obesity treatment trial | 04/11/2024 |
| Begin Period Cash Flow | 3.1 M |
Lipocine |
Lipocine Relative Risk vs. Return Landscape
If you would invest 386.00 in Lipocine on January 20, 2024 and sell it today you would earn a total of 158.00 from holding Lipocine or generate 40.93% return on investment over 90 days. Lipocine is currently generating 0.6857% in daily expected returns and assumes 5.443% risk (volatility on return distribution) over the 90 days horizon. In different words, 48% of stocks are less volatile than Lipocine, and 87% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Lipocine Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lipocine's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Lipocine, and traders can use it to determine the average amount a Lipocine's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.126
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LPCN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.44 actual daily | 48 52% of assets are more volatile |
Expected Return
| 0.69 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Lipocine is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lipocine by adding it to a well-diversified portfolio.
Lipocine Fundamentals Growth
Lipocine Stock prices reflect investors' perceptions of the future prospects and financial health of Lipocine, and Lipocine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lipocine Stock performance.
| Return On Equity | -0.58 | ||||
| Return On Asset | -0.37 | ||||
| Operating Margin | (12.00) % | ||||
| Current Valuation | 3.7 M | ||||
| Shares Outstanding | 5.32 M | ||||
| Price To Earning | 15.80 X | ||||
| Price To Book | 1.47 X | ||||
| Price To Sales | 2.36 X | ||||
| Revenue | 109.99 K | ||||
| Gross Profit | 500 K | ||||
| EBITDA | (14.94 M) | ||||
| Net Income | (16.35 M) | ||||
| Cash And Equivalents | 37.4 M | ||||
| Cash Per Share | 0.42 X | ||||
| Total Debt | 17.17 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 22.23 X | ||||
| Book Value Per Share | 3.83 X | ||||
| Cash Flow From Operations | (11.87 M) | ||||
| Earnings Per Share | (3.14) X | ||||
| Market Capitalization | 25.3 M | ||||
| Total Asset | 23 M | ||||
| Retained Earnings | (199.78 M) | ||||
| Working Capital | 20.23 M | ||||
| Current Asset | 29.41 M | ||||
| Current Liabilities | 1.57 M | ||||
About Lipocine Performance
To evaluate Lipocine Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Lipocine generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Lipocine Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Lipocine market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Lipocine's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.000049 | 0.000047 | |
| Return On Tangible Assets | (0.71) | (0.75) | |
| Return On Capital Employed | (0.73) | (0.70) | |
| Return On Assets | (0.71) | (0.75) | |
| Return On Equity | (0.80) | (0.76) |
Things to note about Lipocine performance evaluation
Checking the ongoing alerts about Lipocine for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lipocine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lipocine is way too risky over 90 days horizon | |
| Lipocine appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 109.99 K. Net Loss for the year was (16.35 M) with profit before overhead, payroll, taxes, and interest of 500 K. | |
| Lipocine currently holds about 37.4 M in cash with (11.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.42. | |
| Lipocine has a poor financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Lipocine reports positive results from obesity treatment trial |
- Analyzing Lipocine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lipocine's stock is overvalued or undervalued compared to its peers.
- Examining Lipocine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lipocine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lipocine's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lipocine's stock. These opinions can provide insight into Lipocine's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Lipocine Stock analysis
When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Revenue Per Share (0.54) | Quarterly Revenue Growth (1.00) | Return On Assets (0.37) | Return On Equity (0.58) |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.